American researchers have developed a versatile, chemically controlled, rapidly activated Cas9 switch, ciCas9, that can grant temporal control over seven Cas9 effectors. CRISPR-Cas effectors are composed of CRISPR RNAs that contain sequences homologous to the invading nucleic acids and Cas proteins specific to each immune system depending on the person. These effectors include two cytidine base editors, two adenine base editors, a dual base editor, a prime editor and a transcriptional activator. Discuss any reactions or share more information that you might have.
top of page
CRISPR AND THE ETHICAL DEBATE SURROUNDING IT
bottom of page